Cross-Over Trial of Intensive Monotherapy With Atorvastatin and Combined Therapy With Atorvastatin and Colestimide for Japanese Familial Hypercholesterolemia-Reference-Cited by-同舟云学术

Cross-Over Trial of Intensive Monotherapy With Atorvastatin and Combined Therapy With Atorvastatin and Colestimide for Japanese Familial Hypercholesterolemia

Published:2006 Issue:1 Volume:70 Page:14-20
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Tasaki Hiromi¹,Miyamoto Masaharu¹,Kubara Takahiro¹,Kamezaki Fumihiko¹,Tanaka Seiya¹,Yamashita Kazuhito¹,Tsutsui Masato²,Nakashima Yasuhide¹

Affiliation:

1. Second Department of Internal Medicine

2. Department of Pharmacology, University of Occupational and Environmental Health, School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/70/1/70_1_14/_pdf

Reference32 articles.

1. Development of coronary heart disease in familial hypercholesterolemia.

2. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

3. Low-density Lipoprotein Apheresis in the Prevention of Recurrent Coronary Heart Disease: A Review

4. Baseline lipid values partly determine the response to high-dose simvastatin in patients with familial hypercholesterolemia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan;Journal of Atherosclerosis and Thrombosis;2018-07-01

2. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy;Journal of Clinical Lipidology;2014-01

3. Lipid lowering efficacy of atorvastatin;Cochrane Database of Systematic Reviews;2012-12-12

4. Avances en el tratamiento de la hipercolesterolemia;Endocrinología y Nutrición;2010-05

5. Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract;Current Pharmaceutical Design;2009-02-01